Efficient Marek's disease virus (MDV) and herpesvirus of turkey infection of the QM7 cell line that does not contain latent MDV genome

References

• Abujoub, A. & Coussens, P.M. (1995). Development of a sustainable chick cell line infected with Marek's disease virus. Virology, 214, 541–549. 10.1006/viro.1995.0065
   PubMed Web of Science ®Google Scholar
• Abujoub, A. & Coussens, P.M. (1997). Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line. Virology, 229, 309–321. 10.1006/viro.1997.8444
   PubMed Web of Science ®Google Scholar
• Antin, P.B. & Ordahl, C.P. (1991). Isolation and characterization of an avian myogenic cell line. Developmental Biology, 143, 111–121. 10.1016/0012-1606(91)90058-B
   PubMed Web of Science ®Google Scholar
• Calnek, B.W., Lucio, B., Schat, K.A. & Lillehoj, H.S. (1989). Pathogenesis of Marek's disease virus – induced local lesions. 1. Lesion characterization and cell line establishment. Avian Diseases, 33, 291–302. 10.2307/1590847
   PubMed Web of Science ®Google Scholar
• Cho, B.R. (1981). A simple in vitro differentiation between turkey herpesvirus and Marek's disease virus. Avian Diseases, 25, 839–846. 10.2307/1590058
   PubMed Web of Science ®Google Scholar
• Davison, A.J. (2010). Herpesvirus systematics. Veterinary Microbiology, 143, 52–69. 10.1016/j.vetmic.2010.02.014
   PubMed Web of Science ®Google Scholar
• Himly, M., Foster, D.N., Bottoli, I., Iacovoni, J.S. & Vogt, P.K. (1998). The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology, 248, 295–304. 10.1006/viro.1998.9290
   PubMed Web of Science ®Google Scholar
• Jaikumar, D., Read, K.M. & Tannock, G.A. (2001). Adaptation of Marek's disease virus to the Vero continuous cell line. Veterinary Microbiology, 79, 75–82. 10.1016/S0378-1135(00)00346-1
   PubMed Web of Science ®Google Scholar
• Lee, L.F., Liu, X. & Witter, R.L. (1983). Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. Journal of Immunology, 130, 1003–1006.
   PubMed Web of Science ®Google Scholar
• Majerciak, V., Valkova, A., Szabova, D., Geerligs, H. & Zelnik, V. (2001). Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to QT35 cells. Acta Virologica, 45, 101–108.
   PubMed Web of Science ®Google Scholar
• Moscovici, C., Moscovici, M.G., Jimenez, H., Lai, M.M.C., Hayman, M.J. & Vogt, P.K. (1977). Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell, 11, 95–103. 10.1016/0092-8674(77)90320-8
   PubMed Web of Science ®Google Scholar
• Nair, V. (2013). Latency and tumorigenesis in Marek's disease. Avian Diseases, 57, 360–365. 10.1637/10470-121712-Reg.1
   PubMedGoogle Scholar
• Niikura, M., Kim, T., Silva, R.F., Dodgson, J. & Cheng, H.H. (2011).Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis. Journal of General Virology, 92, 598–607. 10.1099/vir.0.026864-0
   PubMed Web of Science ®Google Scholar
• Ogura, H. & Fujiwara, T. (1987). Establishment and characterization of a virus-free chick cell line. Acta Medica Okayama, 41, 141–143.
   PubMed Web of Science ®Google Scholar
• Ogura, H., Fujiwara, T. & Namba, M. (1984). Establishment of two chick embryo fibroblastic cell lines. Gann, 75, 410–414.
   PubMedGoogle Scholar
• Osterrieder, N., Kamil, J.P., Schumacher, D., Tischer, B.K. & Trapp, S. (2006). Marek's disease virus: from miasma to model. Nature Reviews Microbiology, 4, 283–294. 10.1038/nrmicro1382
   PubMed Web of Science ®Google Scholar
• Parvizi, P., Abdul-Careem, M.F., Haq, K., Thanthrige-Don, N., Schat, K.A. & Sharif, S. (2010). Immune responses against Marek's disease virus. Animal Health Research Reviews, 11, 123–134. 10.1017/S1466252310000022
   PubMedGoogle Scholar
• Schaefer-Klein, J., Givol, I., Barsov, E.V., Whitcomb, J.M., VanBrocklin, M., Foster, D.N., Federspiel, M.J. & Hughes, S.H. (1998). The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology, 248, 305–311. 10.1006/viro.1998.9291
   PubMed Web of Science ®Google Scholar
• Schat, K.A. (2005). Isolation of Marek's disease virus: revisited. Avian Pathology, 34, 91–95. 10.1080/03079450500059289
   PubMed Web of Science ®Google Scholar
• Schumacher, D., Tischer, B.K., Fuchs, W. & Osterrieder, N. (2000). Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. Journal of Virology, 74, 11088–11098. 10.1128/JVI.74.23.11088-11098.2000
   PubMed Web of Science ®Google Scholar
• Schumacher, D., Tischer, B.K., Reddy, S.M. & Osterrieder, N. (2001). Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. Journal of Virology, 75, 11307–11318. 10.1128/JVI.75.23.11307-11318.2001
   PubMed Web of Science ®Google Scholar
• Schumacher, D., Tischer, B.K., Teifke, J.-P., Wink, K. & Osterrieder, N. (2002). Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E. Journal of General Virology, 83, 1987–1992.
   PubMed Web of Science ®Google Scholar
• Sharma, J.M. (1998). Marek's Disease. In D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, & W.M. Reed (Eds.), A Laboratory Manual for the Isolation and Identification of Avian Pathogens 4th edn (pp.116–124). Kennett Square, PA: American Association of Avian Pathologists.
   Google Scholar
• Sharma, J.M., Witter, R.L. & Burmester, B.R. (1973). Pathogenesis of Marek's disease in old chickens: lesion regression as the basis for age-related resistance. Infection and Immunity, 8, 715–724.
   PubMed Web of Science ®Google Scholar
• Singh, S.M., Baigent, S.J., Petherbridge, L.J., Smith, L.P. & Nair, V.K. (2010). Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus. Research in Veterinary Science, 89, 140–145. 10.1016/j.rvsc.2010.01.010
   PubMed Web of Science ®Google Scholar
• Witter, R.L. (1997). Increased virulence of Marek's disease virus field isolates. Avian Diseases, 41, 149–163. 10.2307/1592455
   PubMed Web of Science ®Google Scholar
• Yamaguchi, T., Kaplan, S.L., Wakenell, P. & Schat, K.A. (2000). Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys. Journal of Virology, 74, 10176–10186. 10.1128/JVI.74.21.10176-10186.2000
   PubMed Web of Science ®Google Scholar
• Zelník, V., Lapuníková, B. & Kúdelová, M. (2013). Marek's disease: rapid progress in research with unclear biological implementations. Acta Virologica, 57, 265–270.
   PubMed Web of Science ®Google Scholar